Background: The guaiac faecal occult blood test (G-FOBT) is recommended as a screening test for colorectal cancer but its low sensitivity has prevented its use throughout the world. Methods: We ...

Objective: The purpose of this study was to evaluate the effectiveness of CT colonography (CTC) as a triage technique in faecal occult blood test (FOBT)-positive screening participants. Methods: ...

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

Multi-targeted stool DNA tests detect significantly more advanced serrated lesions compared with other stool-based tests. While stool-based tests (SBTs) do not show a significant difference in ...

The market for colorectal cancer screening and diagnostics is experiencing significant growth, driven by an increasing interest in at-home testing options. This sector features a dynamic mix of ...

After a maximum follow-up of 14 years, the mean screening participation rate was 63.3%. Those who underwent early screening had reduced risk for colorectal cancer mortality and excess mortality.

DiaCarta, Inc. announced that DiaCarta received US FDA 510 clearance for it’s over the counter at home iColon Fecal Occult Blood Test that enables early detection of blood in stool at home, which is ...

Colorectal cancer (CRC) is a significant public health concern worldwide. Early detection and treatment of CRC can improve patient outcomes and reduce the disease burden. The fecal immunochemical test ...